Literature DB >> 12139308

The promise of toxicogenomics.

Jeffrey F Waring1, Donald N Halbert.   

Abstract

As human genetics and genomics have progressed, culminating in the completion of the rough draft of the human genome in February 2001, new tools and technologies have been developed to identify and quantify global gene expression changes occurring in the cell. These new technologies are allowing researchers to gain an increased understanding of the function and regulation of genes at the systems level, and are transforming virtually all areas of biological research. In the field of toxicology, a new subdiscipline termed toxicogenomics has emerged which promises to identify and characterize the molecular mechanisms that lead to toxicity. Gene expression profiling, through the use of microarray technology, is rapidly becoming a standard analysis in toxicology studies, and has the potential to play a pivotal role in all stages of drug safety evaluation. This review focuses on recent studies in toxicogenomics, and discusses the promises and future challenges in this field.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139308

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  10 in total

1.  Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro.

Authors:  Erik C Gunther; David J Stone; Robert W Gerwien; Patricia Bento; Melvyn P Heyes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

2.  Expression of copper-responsive genes in HepG2 cells.

Authors:  Min Ok Song; Jonathan H Freedman
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

3.  Evaluation of external RNA controls for the standardisation of gene expression biomarker measurements.

Authors:  Alison S Devonshire; Ramnath Elaswarapu; Carole A Foy
Journal:  BMC Genomics       Date:  2010-11-24       Impact factor: 3.969

4.  High-density real-time PCR-based in vivo toxicogenomic screen to predict organ-specific toxicity.

Authors:  Gabriella Fabian; Nora Farago; Liliana Z Feher; Lajos I Nagy; Sandor Kulin; Klara Kitajka; Tamas Bito; Vilmos Tubak; Robert L Katona; Laszlo Tiszlavicz; Laszlo G Puskas
Journal:  Int J Mol Sci       Date:  2011-09-19       Impact factor: 5.923

Review 5.  Toxicogenomics in risk assessment: an overview of an HESI collaborative research program.

Authors:  William Pennie; Syril D Pettit; Peter G Lord
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

6.  Simultaneous clustering of gene expression data with clinical chemistry and pathological evaluations reveals phenotypic prototypes.

Authors:  Pierre R Bushel; Russell D Wolfinger; Greg Gibson
Journal:  BMC Syst Biol       Date:  2007-02-23

7.  Designing toxicogenomics studies that use DNA array technology.

Authors:  Robert R Delongchamp; Cruz Velasco; Varsha G Desai; Taewon Lee; James C Fuscoe
Journal:  Bioinform Biol Insights       Date:  2008-08-14

8.  Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene.

Authors:  Jeffrey F Waring; Roger G Ulrich; Nick Flint; David Morfitt; Arno Kalkuhl; Frank Staedtler; Michael Lawton; Johanna M Beekman; Laura Suter
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

Review 9.  Gene expression profiling: from microarrays to medicine.

Authors:  Ashani T Weeraratna; James E Nagel; Valeria de Mello-Coelho; Dennis D Taub
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

10.  Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells.

Authors:  Sara Abdelfatah; Janine Naß; Caroline Knorz; Sabine M Klauck; Jan-Heiner Küpper; Thomas Efferth
Journal:  Cell Biol Toxicol       Date:  2021-04-21       Impact factor: 6.691

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.